Skip to main content
RecallsAboutBlog

Breckenridge Pharmaceutical, Inc.

Breckenridge Pharmaceutical, Inc.: 2 recalls listed since May 2026 across FDA.

By year

  • 20262

By agency

  • FDA2

By category

  • Drug2

All recalls (2)

Breckenridge Duloxetine Delayed-Release Capsules

Duloxetine Delayed-Release Capsules contain an impurity above the FDA recommended interim limit.

Moderate risk, FDA, , Drug impurity

Breckenridge Pharmaceutical Duloxetine Delayed-Release Capsules

Duloxetine Delayed-Release Capsules contain an impurity above the recommended limit.

Moderate risk, FDA, , Drug impurity
Embed this list